Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefeng Fang

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Annals of Translational Medicine|May 14, 2021
Development and validation of a novel prognostic nomogram including tumor deposits could better predict survival for colorectal cancer: a population-based studyRui Bai, Yinuo Tan, Dan Li, et al.
Plos One|May 4, 2016
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical TrialsLizhen Zhu, Caixia Dong, Ying Cao, et al.
Journal of Cancer Research and Clinical Oncology|October 17, 2019
Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumorsNing Zhu, Shanshan Weng, Juan Wang, et al.
World Journal of Surgical Oncology|November 9, 2012
Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinibYing Yuan, Chunwen Tan, Modan Li, et al.
Plos One|September 25, 2014
Long noncoding RNAs expression patterns associated with chemo response to cisplatin based chemotherapy in lung squamous cell carcinoma patientsZhibo Hou, Chunhua Xu, Haiyan Xie, et al.
Oncotargets and Therapy|August 20, 2016
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerLizhen Zhu, Xiaofen Li, Yanwei Shen, et al.
Frontiers in Genetics|October 17, 2022
REV1: A novel biomarker and potential therapeutic target for various cancersNing Zhu, Yingxin Zhao, Mi Mi, et al.
Current Problems in Cancer|December 18, 2020
Hyperprogressive disease in patients receiving immune checkpoint inhibitorsHaochen Zhang, Xuefeng Fang, Dan Li, et al.
Clinical Chemistry and Laboratory Medicine|April 2, 2020
Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samplesYanqin Huang, Jiayi Mu, Lina Qi, et al.
Virus Research|May 11, 2010
Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunizationShucai Yang, Chunling Wang, Xuefeng Fang, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Annals of Translational Medicine|May 14, 2021
Development and validation of a novel prognostic nomogram including tumor deposits could better predict survival for colorectal cancer: a population-based studyRui Bai, Yinuo Tan, Dan Li, et al.
Plos One|May 4, 2016
Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical TrialsLizhen Zhu, Caixia Dong, Ying Cao, et al.
Journal of Cancer Research and Clinical Oncology|October 17, 2019
Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumorsNing Zhu, Shanshan Weng, Juan Wang, et al.
World Journal of Surgical Oncology|November 9, 2012
Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinibYing Yuan, Chunwen Tan, Modan Li, et al.
Plos One|September 25, 2014
Long noncoding RNAs expression patterns associated with chemo response to cisplatin based chemotherapy in lung squamous cell carcinoma patientsZhibo Hou, Chunhua Xu, Haiyan Xie, et al.
Oncotargets and Therapy|August 20, 2016
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerLizhen Zhu, Xiaofen Li, Yanwei Shen, et al.
Frontiers in Genetics|October 17, 2022
REV1: A novel biomarker and potential therapeutic target for various cancersNing Zhu, Yingxin Zhao, Mi Mi, et al.
Current Problems in Cancer|December 18, 2020
Hyperprogressive disease in patients receiving immune checkpoint inhibitorsHaochen Zhang, Xuefeng Fang, Dan Li, et al.
Clinical Chemistry and Laboratory Medicine|April 2, 2020
Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samplesYanqin Huang, Jiayi Mu, Lina Qi, et al.
Virus Research|May 11, 2010
Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunizationShucai Yang, Chunling Wang, Xuefeng Fang, et al.
Pageof 5